Synsam AB

SYNSAM · Nasdaq Stockholm · Healthcare

52.00SEK +1.2%last day

Price as of 2 October 2026

The price over the past year, with dividends: −7.0%

Performance

1 month

−8.1%

1 year

−7.0%

3 years, per year

+15.6%

5 years, per year

–

Largest fall, 3 years

−53.8%

Below the peak now

−23.5%

Volatility, 1 year

28.4%

Return with dividends reinvested.

Key figures

P/E

12.4

P/B

2.8

Dividend yield

3.5%

Return on equity

+22.6%

Net margin

+7.9%

Market value

736 m USD

Quality, value and trend

Where Synsam stands against every Nordic stock today. 100 is best.

Quality75

Profitability and a sound balance sheet over time. Better than 75% of Nordic stocks.

Value69

The price measured against earnings, assets and cash flow. Better than 69% of Nordic stocks.

Trend29

The price development over the past year. Better than 29% of Nordic stocks.

Combined61

Quality, value and trend together. Better than 61% of Nordic stocks.

About Synsam

Synsam AB is a company in healthcare, listed on Nasdaq Stockholm. The share trades in SEK. It has around 5,600 employees.

Synsam AB (publ), together with its subsidiaries, operates in the optical retail and eye health sector in the Nordic Region. The company offers lenses, frames, sunglasses, sports spectacles, contact lenses, eye care accessories, and hearing aids. It also provides eye health services, hearing tests, lifestyle subscriptions, contact lens subscriptions, personal style advice services, and eye examination services, including physical and online examination services.

See the full analysis in InvestWiser.

The accounts, dividends, 40 years of charts and the comparison with other stocks are in the app.

See the full analysis